Leowattana Wattana, Krudsood Srivicha, Tangpukdee Noppadon, Brittenham Gary, Looareesuwan Sornchai
Department of Clinical Tropical Medicine, Mahidol University, 420/6 Ratchawithi Road, Bangkok 10400, Thailand.
Southeast Asian J Trop Med Public Health. 2008 Jul;39(4):581-8.
To elucidate the relationship between falciparum malaria-associated anemia and serum erythropoietin (Epo) levels and reticulocyte response during acute malaria infection, 87 adults aged 18-65 years presenting with acute, uncomplicated malaria were examined on enrollment and for 28 days of follow-up. The 87 patients were divided into 2 groups: those with anemia (n = 45) and those without (n = 42). Serum samples were taken on admission (Day 0), then on Days 7, 21, and 28, to measure the reticulocyte count, absolute reticulocyte count, reticulocyte hemoglobin content, and erythropoietin level (Epo). The absolute reticulocyte counts for the anemic patients were significantly higher than for those without anemia on Days 0, 7, 21, and 28. The serum Epo levels for the anemic patients were significantly higher than the non-anemic group only on Day 0 (44.39 +/- 4.06 vs 25.91 +/- 4.86 mlU/ml, p < 0.001). Inadequate Epo production was found in 31.03% (27/87) of patients on Day 0, 37.93% (33/87) on Day 7, 43.67% (38/87) on Day 21, and 39.08% (34/87) on Day 28. These results indicate defective Epo production and reticulocyte response in adult patients suffering from acute P. falciparum malaria, which differs from pediatric patients. Our findings may provide the basis for further study into the choice of therapeutic strategies to treat acute P. falciparum malaria-associated anemia with recombinant human Epo to correct refractory anemia due to malaria.
为阐明急性疟疾感染期间恶性疟原虫所致贫血与血清促红细胞生成素(Epo)水平及网织红细胞反应之间的关系,对87例年龄在18 - 65岁、患有急性非复杂性疟疾的成年人在入组时及随访28天期间进行了检查。这87例患者被分为两组:贫血组(n = 45)和非贫血组(n = 42)。在入院时(第0天)、第7天、第21天和第28天采集血清样本,以测定网织红细胞计数、绝对网织红细胞计数、网织红细胞血红蛋白含量和促红细胞生成素水平(Epo)。在第0天、第7天、第21天和第28天,贫血患者的绝对网织红细胞计数显著高于非贫血患者。贫血患者的血清Epo水平仅在第0天显著高于非贫血组(44.39±4.06 vs 25.91±4.86 mlU/ml,p < 0.001)。在第0天,31.03%(27/87)的患者促红细胞生成素产生不足;第7天为37.93%(33/87);第21天为43.67%(38/87);第28天为39.08%(34/87)。这些结果表明,成年急性恶性疟患者存在促红细胞生成素产生缺陷和网织红细胞反应异常,这与儿童患者不同。我们的研究结果可能为进一步研究用重组人促红细胞生成素治疗急性恶性疟原虫所致贫血以纠正疟疾难治性贫血的治疗策略选择提供依据。